Julie Caramel

3.3k total citations · 1 hit paper
29 papers, 2.1k citations indexed

About

Julie Caramel is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Julie Caramel has authored 29 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 15 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Julie Caramel's work include CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (7 papers) and Melanoma and MAPK Pathways (6 papers). Julie Caramel is often cited by papers focused on CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (7 papers) and Melanoma and MAPK Pathways (6 papers). Julie Caramel collaborates with scholars based in France, United States and Germany. Julie Caramel's co-authors include Alain Puisieux, Thomas Brabletz, Stéphane Dalle, Geoffrey Richard, Olivier Delattre, Stéphane Ansieau, Frédérique Quignon, Eugene Tulchinsky, Peter J. Hutchinson and James H. Pringle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Julie Caramel

29 papers receiving 2.1k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncogenic roles of EMT-inducing transcription factors

2014 823 citations Alain Puisieux, Thomas Brabletz et al. Nature Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie Caramel France	15	1.4k	924	562	290	236	29	2.1k
Susan Mason United Kingdom	17	1.4k 1.0×	648 0.7×	673 1.2×	356 1.2×	202 0.9×	33	2.1k
Paola Ghiorzo Italy	26	1.1k 0.7×	1.1k 1.2×	528 0.9×	264 0.9×	195 0.8×	79	1.9k
Minji Jo United States	23	1.6k 1.1×	796 0.9×	902 1.6×	444 1.5×	216 0.9×	33	2.5k
Trevor G. Shepherd Canada	26	1.1k 0.8×	644 0.7×	406 0.7×	157 0.5×	189 0.8×	64	1.8k
Kensuke Kojima Japan	29	1.8k 1.2×	1.1k 1.2×	283 0.5×	327 1.1×	174 0.7×	135	2.9k
Judy Wai Ping Yam Hong Kong	27	1.8k 1.3×	478 0.5×	769 1.4×	300 1.0×	443 1.9×	94	2.4k
Raleigh D. Kladney United States	23	996 0.7×	505 0.5×	434 0.8×	281 1.0×	258 1.1×	33	1.8k
Charles D. Lopez United States	23	987 0.7×	1.0k 1.1×	375 0.7×	201 0.7×	117 0.5×	97	1.8k
Kwan Man Hong Kong	17	1.7k 1.2×	743 0.8×	1.3k 2.2×	226 0.8×	219 0.9×	24	2.5k
M. Phillip DeYoung United States	10	1.3k 0.9×	745 0.8×	435 0.8×	123 0.4×	224 0.9×	18	1.8k

Countries citing papers authored by Julie Caramel

Since Specialization

Citations

This map shows the geographic impact of Julie Caramel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Caramel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Caramel more than expected).

Fields of papers citing papers by Julie Caramel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Caramel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Caramel. The network helps show where Julie Caramel may publish in the future.

Co-authorship network of co-authors of Julie Caramel

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Caramel. A scholar is included among the top collaborators of Julie Caramel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Caramel. Julie Caramel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Durand, Simon, et al.. (2025). ZEB1 transcription factor induces tumor cell PD-L1 expression in melanoma. Cancer Immunology Immunotherapy. 74(4). 141–141. 1 indexed citations

Durand, Simon, et al.. (2024). ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions. Oncogene. 43(20). 1489–1505. 5 indexed citations

Dalle, Stéphane, Estelle Verronèse, Céline Rodriguez, et al.. (2024). Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients. OncoImmunology. 13(1). 2372118–2372118. 1 indexed citations

Cario, Muriel, Simon Durand, Manfred Schartl, et al.. (2024). Cancer Cell Biomechanical Properties Accompany Tspan8-Dependent Cutaneous Melanoma Invasion. Cancers. 16(4). 694–694. 2 indexed citations

Dalle, Stéphane, et al.. (2023). An in vivo avian model of human melanoma to perform rapid and robust preclinical studies. EMBO Molecular Medicine. 15(3). e16629–e16629. 2 indexed citations

Tonon, Laurie, Jonathan Lopez, B. Balme, et al.. (2022). ZEB1 transcription factor promotes immune escape in melanoma. Journal for ImmunoTherapy of Cancer. 10(3). e003484–e003484. 55 indexed citations

Houlier, Aurélie, Daniel Pissaloux, Franck Tirode, et al.. (2021). RASGRF2 gene fusions identified in a variety of melanocytic lesions with distinct morphological features. Pigment Cell & Melanoma Research. 34(6). 1074–1083. 13 indexed citations

Cario, Muriel, Marilyne Malbouyres, Florence Ruggiero, et al.. (2020). Stiffness measurement is a biomarker of skin ageing in vivo. Experimental Dermatology. 29(12). 1233–1237. 10 indexed citations

Bouché, Mathilde, Georges Dahm, Gabriel Ichim, et al.. (2020). In Cellulo Evaluation of the Therapeutic Potential of NHC Platinum Compounds in Metastatic Cutaneous Melanoma. International Journal of Molecular Sciences. 21(21). 7826–7826. 3 indexed citations

10.

Durand, Simon, et al.. (2020). EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment. Cancers. 12(8). 2154–2154. 60 indexed citations

11.

Pommier, Roxane M., Arnaud de la Fouchardière, Lionel Larue, et al.. (2019). Tspan8-β-catenin positive feedback loop promotes melanoma invasion. Oncogene. 38(20). 3781–3793. 18 indexed citations

12.

Descôtes, Françoise, B. Balme, L. Depaepe, et al.. (2019). The dynamic molecular landscape of malignant melanomas arising from congenital or common nevi. Integrative Molecular Medicine. 6(3). 1 indexed citations

13.

Rodier, Geneviève, Olivier Kirsh, Martín A. Baraibar, et al.. (2015). The Transcription Factor E4F1 Coordinates CHK1-Dependent Checkpoint and Mitochondrial Functions. Cell Reports. 11(2). 220–233. 33 indexed citations

14.

Puisieux, Alain, Thomas Brabletz, & Julie Caramel. (2014). Oncogenic roles of EMT-inducing transcription factors. Nature Cell Biology. 16(6). 488–494. 823 indexed citations breakdown →

15.

Caramel, Julie, Louise Hill, Gareth J. Browne, et al.. (2013). A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma. Cancer Cell. 24(4). 466–480. 378 indexed citations

16.

Hatchi, Elodie, Geneviève Rodier, Matthieu Lacroix, et al.. (2011). E4F1 deficiency results in oxidative stress–mediated cell death of leukemic cells. The Journal of Experimental Medicine. 208(7). 1403–1417. 18 indexed citations

17.

Caramel, Julie, Frédérique Quignon, & Olivier Delattre. (2008). RhoA-Dependent Regulation of Cell Migration by the Tumor Suppressor hSNF5/INI1. Cancer Research. 68(15). 6154–6161. 42 indexed citations

18.

Caramel, Julie, Souhila Medjkane, Frédérique Quignon, & Olivier Delattre. (2007). The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors. Oncogene. 27(14). 2035–2044. 47 indexed citations

19.

Cougot, Delphine, Yuanfei Wu, Stefano Cairo, et al.. (2006). The Hepatitis B Virus X Protein Functionally Interacts with CREB-binding Protein/p300 in the Regulation of CREB-mediated Transcription. Journal of Biological Chemistry. 282(7). 4277–4287. 166 indexed citations

20.

Caramel, Julie, F. Bonnel, & Pierre Rabischong. (1983). The oculomotor nerve: biometry and endoneural fascicular systematization. Surgical and Radiologic Anatomy. 5(3). 159–168. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact